Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Tonix Pharmaceuticals Holding (TNXP) Income from Continuing Operations: 2023-2025

Historic Income from Continuing Operations for Tonix Pharmaceuticals Holding (TNXP) over the last 2 years, with Sep 2025 value amounting to -$31.8 million.

  • Tonix Pharmaceuticals Holding's Income from Continuing Operations fell 101.02% to -$31.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$98.0 million, marking a year-over-year increase of 30.87%. This contributed to the annual value of -$136.7 million for FY2024, which is 39.20% down from last year.
  • Tonix Pharmaceuticals Holding's Income from Continuing Operations amounted to -$31.8 million in Q3 2025, which was down 15.06% from -$27.7 million recorded in Q2 2025.
  • In the past 5 years, Tonix Pharmaceuticals Holding's Income from Continuing Operations ranged from a high of -$15.8 million in Q3 2024 and a low of -$77.3 million during Q2 2024.
  • For the 3-year period, Tonix Pharmaceuticals Holding's Income from Continuing Operations averaged around -$29.8 million, with its median value being -$27.3 million (2023).
  • Within the past 5 years, the most significant YoY rise in Tonix Pharmaceuticals Holding's Income from Continuing Operations was 64.21% (2025), while the steepest drop was 101.02% (2025).
  • Quarterly analysis of 3 years shows Tonix Pharmaceuticals Holding's Income from Continuing Operations stood at -$27.3 million in 2023, then climbed by 17.72% to -$22.5 million in 2024, then tumbled by 101.02% to -$31.8 million in 2025.
  • Its Income from Continuing Operations was -$31.8 million in Q3 2025, compared to -$27.7 million in Q2 2025 and -$16.1 million in Q1 2025.